Re-exploring the anthracycline chemical space for better anti-cancer compounds

Gelder, M.A.; Zanden, S.Y. van der; Vriends, M.B.L.; Wagensveld, R.A.; Marel, G.A. van der; Codee, J.D.C.; ... ; Neefjes, J.J.C. (2023)

Article / Letter to editor

The anthracycline anti-cancer drugs are intensely usedin the clinicto treat a wide variety of cancers. They generate DNA double strandbreaks, but recently the induction of chromatin damage was introducedas another major determinant of anti-cancer activity. The combinationof these two events results in their reported side effects. Whileour knowledge on the structure-activity relationship of anthracyclineshas improved, many structural variations remain poorly explored. Therefore,we here report on the preparation of a diverse set of anthracyclineswith variations within the sugar moiety, amine alkylation pattern,saccharide chain and aglycone. We assessed the cytotoxicity in vitro in relevant human cancer cell lines, and the capacityto induce DNA- and chromatin damage. This coherent set of data allowedus to deduce a few guidelines on anthracycline design, as well asdiscover novel, highly potent anthracyclines that may be better toleratedby patients.

• All authors: Gelder, M.A.; Zanden, S.Y. van der; Vriends, M.B.L.; Wagensveld, R.A.; Marel, G.A. van der; Codee, J.D.C.; Overkleeft, H.S.; Wander, D.P.A.; Neefjes, J.J.C.
• Date: 2023-08-10
• Journal: Journal of Medicinal Chemistry
• Volume: 66
• Issue: 16
• Pages: 11390–11398
• DOI: doi:10.1021/acs.jmedchem.3c00853
• Link: https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00853